Immunovant, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Immunovant, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Immunovant, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 147M shares, a 11.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 147M +15.1M +11.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 146M +15.6M +12% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 146M +15.3M +11.7% Mar 31, 2024 10-Q 2024-11-07
Q4 2023 145M +15.8M +12.3% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 131M +14.8M +12.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 131M +14M +12.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 130M +13.8M +11.9% Mar 31, 2023 10-K 2024-05-29
Q4 2022 129M +14.2M +12.3% Dec 31, 2022 10-Q 2023-02-03
Q3 2022 117M +1.62M +1.41% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 117M +18.5M +18.9% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 116M +18.5M +18.9% Mar 31, 2022 10-K 2023-05-22
Q4 2021 115M +17.1M +17.5% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 115M +17.1M +17.5% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 98M +17.1M +21.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 98M +43.3M +79.3% Mar 31, 2021 10-K 2022-06-08
Q4 2020 98M +43.3M +79.3% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 97.9M +94.4M +2671% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 80.9M +77.4M +2182% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 54.7M +16.1M +41.6% Mar 31, 2020 10-K 2021-06-01
Q4 2019 54.7M +51.8M +1801% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 3.53M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 3.55M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 38.6M Mar 31, 2019 10-K 2020-06-29
Q4 2018 2.88M Dec 31, 2018 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.